Trends in initial management of prostate cancer in New Hampshire

Ingimarsson, Johann P.; Celaya, Maria O.; Laviolette, M; Rees, Judy R.; Hyams, Elias S.

doi:10.1007/s10552-015-0574-8

Cited by 23 publications

(16 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, though, more recent year (post‐2006) diagnoses were associated with higher likelihood of single‐trip intervention, which largely represented surgery. This reflects our recent findings, published separately, that surgical intervention has become significantly more common for all risk categories in recent years in New Hampshire, likely because of changing treatment paradigms (ie, more aggressive use of surgery for higher‐risk cancer) and the advent of robotic surgery to the state . Finally, “married” status was associated with XRT; speculatively, it may be that those who are married have greater logistical support for daily treatments.…”

Section: Discussionsupporting

confidence: 65%

Does Travel Time to a Radiation Facility Impact Patient Decision‐Making Regarding Treatment for Prostate Cancer? A Study of the New Hampshire State Cancer Registry

Ghali

Celaya

Laviolette³

et al. 2016

The Journal of Rural Health

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 65%

Does Travel Time to a Radiation Facility Impact Patient Decision‐Making Regarding Treatment for Prostate Cancer? A Study of the New Hampshire State Cancer Registry

Ghali

Celaya

Laviolette³

et al. 2016

The Journal of Rural Health

Self Cite

View full text Add to dashboard Cite

show abstract

“…This decline likely comes from the decreasing cebp.aacrjournals.org Downloaded from incidence of prostate cancer, which mostly reflects changes in prostate-specific antigen (PSA) screening (13,14). In addition, changes in patterns of treatment including more men choosing active surveillance may reduce the number of men undergoing radiation therapy (15,16). The landscape of prostate cancer survivorship may continue to evolve with the recently published PROTECT study that found similar cancer-specific survival among active surveillance, surgery, and radiation in earlystage prostate cancer (17,18).…”

Section: Discussionmentioning

confidence: 99%

Trends in Radiation Therapy among Cancer Survivors in the United States, 2000–2030

Bryant

Banegas

Martı́nez

et al. 2017

Cancer Epidemiology, Biomarkers &Amp; Prevention

109

View full text Add to dashboard Cite

Background: Although the number of cancer survivors has increased substantially over the past several decades, the composition of survivors treated with radiotherapy is not well defined. Radiotherapy carries unique long-term toxicity risks for cancer survivors. This study describes the current estimates and future projections of the epidemiology of 5-year cancer survivors who receive radiation therapy.Methods: We used cancer incidence and survival data from the Surveillance, Epidemiology, and End-Results (SEER) database linked to U.S. Census data to estimate the number of 5-year cancer survivors treated with radiation between 2000 and 2030. Future projections assumed continuing incidence and survival trends based on historical rates.Results: In 2016, there were an estimated 3.05 million cancer survivors treated with radiation, accounting for 29% of all

show abstract

“…This use of active surveillance is substantially higher than that reported in the United States. 1,9,10 Potential facilitating factors for the rapid uptake of active surveillance in Sweden include 2007 national guidelines recommending active surveillance for men with low-risk prostate cancer and a life expectancy of 10 to 20 years. In 2014, the 20-year upper limit for life expectancy was abandoned, and active surveillance was recommended for all men with very-low-risk prostate cancer.…”

Section: Brief Reportmentioning

confidence: 99%

Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

et al. 2017

View full text Add to dashboard Cite

Importance Active surveillance is an important option to reduce prostate cancer overtreatment, but it remains underutilized in many countries. Models from the United States show that greater use of active surveillance is important for prostate cancer screening to be cost-effective. Objectives To perform an up-to-date, nationwide, population-based study on use of active surveillance for localized prostate cancer in Sweden. Design Cross-sectional study in the National Prostate Cancer Register (NPCR) of Sweden from 2009 through 2014. Setting The NPCR has data on 98% of prostate cancers diagnosed in Sweden and has comprehensive linkages to other nationwide databases. Participants Overall, 32 518 men with a median age of 67 years were diagnosed with favorable-risk prostate cancer, including 4 693, 15 403 and 17 115 men with very-low-risk (subset of the low-risk group) (clinical stage, T1c; Gleason score, ≤6; prostate-specific antigen [PSA], <10 ng/ml; PSA density <0.15ng/mL/cm3; and <8-mm total cancer length in ≤4 positive biopsy cores), low-risk (including all men in the very-low-risk group) (T1–T2; Gleason score, ≤6; and PSA, <10ng/mL), and intermediate-risk disease (T1–T2 with Gleason score, 7 and/or PSA, 10–20ng/mL). Exposures Diagnosis with favorable-risk prostate cancer Major Outcome Utilization of active surveillance Results The use of active surveillance increased in men of all ages from 57% (380 of 665) to 91% (939 of 1027) for very-low-risk prostate cancer and from 40% (1159 of 2895) to 74% (1951 of 2644) for low-risk prostate cancer, with the strongest increase occurring from 2011 onward. Among men aged 50 to 59 years, 88% (211 of 240) with very-low-risk and 68% (351 of 518) with low-risk disease chose active surveillance in 2014. Use of active surveillance for intermediate-risk disease remained lower, 19% (561 of 3030) in 2014. Conclusions and Relevance Active surveillance has become the dominant management for low-risk prostate cancer among men in Sweden, with the highest rates yet reported and almost complete uptake for very-low-risk cancer. These data should serve as a benchmark to compare the use of active surveillance for favorable-risk disease around the world.

show abstract

Trends in initial management of prostate cancer in New Hampshire

Abstract: There are encouraging trends in the management of clinically localized prostate cancer in New Hampshire, including less aggressive treatment of low-risk cancer and increasing surgical treatment of high-risk disease.

Cited by 23 publications

References 23 publications

Does Travel Time to a Radiation Facility Impact Patient Decision‐Making Regarding Treatment for Prostate Cancer? A Study of the New Hampshire State Cancer Registry

Does Travel Time to a Radiation Facility Impact Patient Decision‐Making Regarding Treatment for Prostate Cancer? A Study of the New Hampshire State Cancer Registry

Trends in Radiation Therapy among Cancer Survivors in the United States, 2000–2030

Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

Contact Info

Product

Resources

About